IC(Interventional Cardiology) 기기 시장 규모, 점유율, 성장 분석 : 제품별, 최종사용자별, 지역별 - 산업별 예측(2024-2031년)
Interventional Cardiology Devices Market Size, Share, Growth Analysis, By Product (Coronary Stents, Structural Heart Devices), By End User (Hospitals & ASCS, Catheterization Labs & Others), By Region - Industry Forecast 2024-2031
세계의 IC(Interventional Cardiology) 기기 시장 규모는 2022년에 131억 달러로 평가되며, 2023년 140억 6,000만 달러에서 2031년에는 247억 달러로 성장하며, 예측 기간 중(2024-2031년) CAGR은 7.3%로 성장할 전망입니다.
IC(Interventional Cardiology) 기기 시장은 혁신적인 심혈관 기기의 발전으로 크게 성장하고 있습니다. 중재적 심장 전문의는 심혈관 질환에 대한 교육을 받은 전문의로서 주로 카테터(혈관 성형술이나 스텐트 삽입술과 같은 최소 침습적 시술을 용이하게 하는 플렉서블 튜브)를 사용하는 전문가입니다. 이러한 시술은 종종 고혈압과 당뇨병을 동반한 다양한 심장질환을 가진 환자들에게 개복 수술에 대한 대안이 될 수 있습니다. 또한 이러한 기기는 사지 동맥에 플라크가 쌓이는 말초 혈관 문제도 해결할 수 있습니다. 시장에는 카테터, 풍선, 스텐트, 필터 등이 있습니다. 규제 승인 획득이 용이하다는 점은 시장 확대에 긍정적으로 작용하고 있지만, 엄격한 정부 규제와 승인 절차로 인한 과제가 남아 있으며, 이 분야의 전반적인 성장 잠재력을 저해할 수 있습니다.
목차
서론
조사 방법
- 정보 조달
- 2차 데이터와 1차 데이터 방법
- 시장 규모 예측
- 시장의 전제조건과 제한
개요
- 세계 시장 전망
- 공급과 수요의 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 산업 분석
주요 시장 인사이트
- 주요 성공 요인
- 경쟁의 정도
- 주요 투자 기회
- 시장 에코시스템
- 시장의 매력 지수(2023년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 기술의 진보
- 규제 상황
- 사례 연구
- 고객과 구매 기준 분석
- 무역 분석
- 원재료 분석
IC(Interventional Cardiology) 기기 시장 규모 : 제품별
- 시장 개요
- 관상동맥 스텐트
- 베어메탈 스텐트(Bms)
- 약제용출스텐트(Des)
- 기타
- 구조적 심장 디바이스
- 혈관성형술용 풍선
- 카테터
- 진단용 카테터
- 혈관조영검사
- IVUS
- 치료용 카테터
- 죽종 절제술
- 혈전 제거술
- 절제
- 색전보호 디바이스
IC(Interventional Cardiology) 기기 시장 규모 : 최종사용자별
- 시장 개요
- 병원과 ASC
- 카테터 검사실 및 기타
IC(Interventional Cardiology) 기기 시장 규모 : 지역별
- 북미
- 유럽
- 독일
- 스페인
- 프랑스
- 영국
- 이탈리아
- 기타 유럽 지역
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 상위 5사의 비교
- 주요 기업의 시장 포지셔닝(2023년)
- 주요 시장 기업이 채택한 전략
- 시장의 최근 동향
- 기업의 시장 점유율 분석(2023년)
- 주요 기업의 기업 개요
- 회사 개요
- 제품 포트폴리오 분석
- 부문별 점유율 분석
- 매출의 전년대비 비교(2021-2023)
주요 기업 개요
- Abbott Laboratories
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Medtronic PLC
- Terumo Corporation
- Biotronik SE & Co. KG
- Biosensors International Group Ltd
- ACIST Medical Systems
- Cardinal Health, Inc.
- Cook Medical Inc.
- Koninklijke Philips N.V.
- Edwards Lifesciences Corporation
- Nano Therapeutics Pvt. Ltd.
- AngioDynamics, Inc.
- Inari Medical, Inc.
- Genetesis, Inc.
- OptiMed Medical Instruments GmbH
- Meril Life Sciences Pvt. Ltd.
- OrbusNeich Medical
결론과 권장사항
KSA
Global Interventional Cardiology Devices Market size was valued at USD 13.1 billion in 2022 and is poised to grow from USD 14.06 billion in 2023 to USD 24.7 billion by 2031, growing at a CAGR of 7.3% during the forecast period (2024-2031).
The market for interventional cardiology is seeing significant growth driven by advancements in innovative cardiovascular devices. Interventional cardiologists, trained specialists in cardiovascular diseases, primarily utilize catheters-flexible tubes that facilitate minimally invasive procedures like angioplasty and stenting. These techniques offer a viable alternative to open surgery for patients with various heart conditions, often associated with hypertension and diabetes. Additionally, these devices address peripheral vascular problems that lead to plaque build-up in limb arteries. Market offerings include catheters, balloons, stents, and filters. While the ease of obtaining regulatory licenses contributes positively to market expansion, challenges remain due to stringent government regulations and approval processes that may hinder overall growth potential in this sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Interventional Cardiology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Interventional Cardiology Devices Market Segmental Analysis
Global Interventional Cardiology Devices Market is segmented by product, end user and region. Based on product, the market is segmented into coronary stents, structural heart devices, angioplasty balloons, catheters and embolic protection devices. Based on end user, the market is segmented into hospitals & ASCS and catheterization labs & others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Interventional Cardiology Devices Market
The global interventional cardiology devices market is primarily driven by the increasing prevalence of lifestyle habits such as high saturated fat intake, excessive salt consumption, alcohol use, and smoking, all of which contribute significantly to the risk of coronary artery disease (CAD). The rise in tobacco use and sedentary lifestyles further exacerbates this issue, leading to a growing incidence of obesity and CAD, thereby propelling the demand for interventional cardiology devices. As individuals become more aware of the health implications associated with these habits, there is a heightened need for advanced medical solutions, thus fostering growth in the interventional cardiology devices sector.
Restraints in the Global Interventional Cardiology Devices Market
The Global Interventional Cardiology Devices market faces significant restraints due to the evolving and complicated regulatory standards that govern medical device approvals. These regulations are influenced by various legal factors and are particularly challenging to navigate. Stringent scrutiny is required to ensure that medical devices meet high performance and quality benchmarks, which is essential for safeguarding public safety. Consequently, these rigorous and intricate certification processes may hinder the growth of the market, as manufacturers strive to comply with such demanding requirements while also trying to adapt to the changing needs of customers and the healthcare landscape.
Market Trends of the Global Interventional Cardiology Devices Market
The Global Interventional Cardiology Devices market is witnessing significant growth, driven primarily by the rising prevalence of obesity-related cardiovascular diseases and an increase in coronary artery disease due to unhealthy lifestyle choices. As sedentary lifestyles, smoking, and excessive alcohol consumption become more common, the demand for advanced interventional cardiology devices is surging. These devices offer cardiologists the ability to conduct life-saving procedures with improved safety and efficiency, minimizing complications. Consequently, the market is poised for expansion, fueled by technological advancements and an increasing focus on preventive and interventional cardiac care. As awareness grows, investment in innovative solutions will likely contribute to sustained market momentum.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2023
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Technological Advancement
- Regulatory Landscape
- Case Studies
- Customer & Buying Criteria Analysis
- Trade Analysis
- Raw Material Analysis
Global Interventional Cardiology Devices Market Size by Product & CAGR (2024-2031)
- Market Overview
- Coronary Stents
- Bare-Metal Stent (Bms)
- Drug-Eluting Stent (Des)
- Others
- Structural Heart Devices
- Heart Valves
- Occluders & Others
- Angioplasty Balloons
- Catheters
- Diagnostic Catheters
- Angiography
- Ivus
- Treatment Catheters
- Atherectomy
- Thrombectomy
- Ablation
- Embolic Protection Devices
Global Interventional Cardiology Devices Market Size by End User & CAGR (2024-2031)
- Market Overview
- Hospitals & Ascs
- Catheterization Labs & Others
Global Interventional Cardiology Devices Market Size & CAGR (2024-2031)
- North America (Product, End User)
- Europe (Product, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Product, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2023
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2023
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)
Key Company Profiles
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biotronik SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biosensors International Group Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ACIST Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Edwards Lifesciences Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nano Therapeutics Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AngioDynamics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inari Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genetesis, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OptiMed Medical Instruments GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Meril Life Sciences Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OrbusNeich Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
